News
After a decade and 130 million dollars, the MeMed test receives FDA clearance
Amy Crosby 27 October 2021
Maccabi Healthcare Services Announces it is the First HMO in the World to Include MeMed BV® Test as Part of Routine Care
Amy Crosby 07th June 2022
DiaSorin receives FDA 510(K) clearance for Its LIAISON MeMed BV test
Amy Crosby 25th July 2022
MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio
Amy Crosby 10th January 2022
Maimonides Medical Center adopts revolutionary technology that quickly distinguishes bacterial and viral Infections
Amy Crosby 22nd March 2022
2021 Dun & Bradstreet's Best Companies to Work For
Amy Crosby 31st December 2021
Platform distinguishing between viral and bacterial infections cleared by FDA
Amy Crosby 28th September 2021
FDA Clears New Technology to Differentiate Bacterial, Viral Infections Using Biomarkers
Amy Crosby 28th September 2021
Bacterial and Viral Biomarker Test Gains US FDA Clearance
Amy Crosby 27th September 2021
MeMed Gets FDA 510(k) Clearance for Test Distinguishing Between Viral, Bacterial Infections
Amy Crosby 27th September 2021
Israel’s MeMed gets FDA approval for ‘breakthrough’ infection test
Amy Crosby 26th September 2021
MeMed Received FDA Clearance for Infection Test
Amy Crosby 26th September 2021
FDA clears MeMed’s point-of-need infectious disease test
Amy Crosby 26th September 2021
US approves MeMed test to distinguish bacterial from viral infections
Amy Crosby 26th September 2021
MeMed’s Diagnostics, BV Test and Key Platform Get 510(k) Clearance
Amy Crosby 26th September 2021
Rapid test to distinguish bacterial and viral infections wins US approval
Amy Crosby 20th September 2021
Pioneering test which can indicate COVID-19 severity receives CE Mark
Amy Crosby 12th September 2021
COVID-19 severity test is approved for sale in the UK
Amy Crosby 11th September 2021
Longitude Prize: Bacterial or Viral: To Treat or Not to Treat with Antibiotics
Amy Crosby 04th September 2017
Test predicting COVID-19 severity receives CE mark
Amy Crosby 27th July 2021
MeMed’s Covid-19 severity test receives its CE Mark to predict severe outcomes
Amy Crosby 27th July 2021
MeMed Wins $4.1M DOD Grant toward Manufacturing of POC Platform
Amy Crosby 16th February 2018
MeMed Receives CE Mark for Diagnostic Platform & Infection Assay
Amy Crosby 04th June 2021
MeMed's co-founder and CEO, Dr. Eran Eden on the BioBoss Podcast
Amy Crosby 25th September 2020
Israeli firm advances diagnostic solutions for Covid-19
Amy Crosby 07th July 2020
Interview with Eran Eden, MeMed's CEO
Amy Crosby 27th March 2020
Israeli Startups Join The Fight Against Coronavirus
Amy Crosby 18th March 2020
OurCrowd Portfolio Companies Pivot to Tackle Coronavirus Pandemic
Amy Crosby 07th March 2020
Technology Pioneers 2019
Amy Crosby 27th April 2019
Rapid blood test to 'cut antibiotic use'
Amy Crosby 27th March 2015
A New Blood Test Could Stop Doctors From Overprescribing Antibiotics
Amy Crosby 17th September 2013